Price Performance
- Day's Low
- ₹947.5
- Day's High
- ₹983.35
₹ 951.2
- 52-w low
- ₹530.55
- 52-w high
- ₹1,108.35
951.2
- Day's open
₹954.7 - Previous close
₹948.950012 - VWAP
₹962.59 - Lower price band
₹759.2 - Upper price band
₹1,138.70
Today's Market Action
The last traded share price of Natco Pharma Ltd was 951.20 up by 0.24% on the NSE. Its last traded stock price on BSE was 950.15 up by 0.12%. The total volume of shares on NSE and BSE combined was 822,813 shares. Its total combined turnover was Rs 79.20 crores.
Medium and Long Term Market Action
Natco Pharma Ltd hit a 52-week high of 1,108.35 on 19-02-2024 and a 52-week low of 530.55 on 27-03-2023.
The stock price of Natco Pharma Ltd is up by 8% over the last one month. It is up by 78.41% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 16997
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Natco Pharma Ltd?
What is the Market Cap of Natco Pharma Ltd?
What is PE Ratio of Natco Pharma Ltd?
What is PB Ratio of Natco Pharma Ltd?
What is the CAGR of Natco Pharma Ltd?
How to Buy Natco Pharma Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Above Average Sustainable RoE
Great Cash Conversion of Profits
High Pricing Power
Zero Debt
High Shareholder Pedigree
Cons
Highly Cyclical Industry
Capital Intensive Business
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(19/03/2024)
(19/03/2024)
93
100.00%
100.00% People are bullish about Natco Pharma Ltd
0.00%
0.00 % People are bearish about Natco Pharma Ltd